Plasma p-tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach.

Key Points

• The aim is to evaluate the use of plasma p-tau217 in diagnosing Alzheimer's disease and its integration into clinical settings.
• Assessment of plasma p-tau217 levels in patients at memory clinics
• Evaluation of clinical validity within diagnostic pathways
• Structured integration approach for routine application
• Plasma p-tau217 showed strong clinical validity for Alzheimer's diagnosis
• Supports incorporation into existing diagnostic routines